Digital tech could unlock £22 billion for UK pharma, Accenture claims

Harnessing digital technologies could unlock £22 billion ($30.1 billion) for UK pharma companies over the next decade, according to Accenture.

The study found that pharma could accelerate growth by 5%, generating an estimated £12 billion in new revenue. On top of this, it could reduce costs by more than £11 billion and pass on cost savings of 10% direct to consumers.

"Pharma companies must look at how they reinvent operating models, production and value chains"